CA2362051C - Methods and compositions for use in perfusion applications - Google Patents

Methods and compositions for use in perfusion applications Download PDF

Info

Publication number
CA2362051C
CA2362051C CA2362051A CA2362051A CA2362051C CA 2362051 C CA2362051 C CA 2362051C CA 2362051 A CA2362051 A CA 2362051A CA 2362051 A CA2362051 A CA 2362051A CA 2362051 C CA2362051 C CA 2362051C
Authority
CA
Canada
Prior art keywords
subject
solution
blood
fluid
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2362051A
Other languages
English (en)
French (fr)
Other versions
CA2362051A1 (en
Inventor
Paul E. Segall
Harold D. Waitz
Hal Sternberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lineage Cell Therapeutics Inc
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of CA2362051A1 publication Critical patent/CA2362051A1/en
Application granted granted Critical
Publication of CA2362051C publication Critical patent/CA2362051C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2362051A 1999-02-03 2000-01-24 Methods and compositions for use in perfusion applications Expired - Fee Related CA2362051C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/243,921 1999-02-03
US09/243,921 US6589223B1 (en) 1999-02-03 1999-02-03 Method and compositions for use in perfusion applications
PCT/US2000/001703 WO2000045873A1 (en) 1999-02-03 2000-01-24 Methods and compositions for use in perfusion applications

Publications (2)

Publication Number Publication Date
CA2362051A1 CA2362051A1 (en) 2000-08-10
CA2362051C true CA2362051C (en) 2010-06-29

Family

ID=22920663

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2362051A Expired - Fee Related CA2362051C (en) 1999-02-03 2000-01-24 Methods and compositions for use in perfusion applications

Country Status (14)

Country Link
US (3) US6589223B1 (cg-RX-API-DMAC7.html)
EP (1) EP1150728A4 (cg-RX-API-DMAC7.html)
JP (2) JP2002536078A (cg-RX-API-DMAC7.html)
CN (1) CN1200742C (cg-RX-API-DMAC7.html)
AR (1) AR022482A1 (cg-RX-API-DMAC7.html)
AU (1) AU765144B2 (cg-RX-API-DMAC7.html)
BR (1) BR0008006A (cg-RX-API-DMAC7.html)
CA (1) CA2362051C (cg-RX-API-DMAC7.html)
EA (1) EA003171B1 (cg-RX-API-DMAC7.html)
IL (1) IL144710A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01007875A (cg-RX-API-DMAC7.html)
TW (1) TW542728B (cg-RX-API-DMAC7.html)
WO (1) WO2000045873A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200107243B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
US7354342B2 (en) * 2003-07-30 2008-04-08 Igt Gaming device having a multiple coordinate award distributor including award percentages
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US8304181B2 (en) * 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
NZ600702A (en) 2004-10-07 2013-12-20 Transmedics Inc Systems and methods for ex-vivo organ care
WO2007005285A2 (en) * 2005-06-22 2007-01-11 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Emergency preservation and resuscitation methods
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US8286159B2 (en) * 2005-12-22 2012-10-09 Alan Joshua Shapiro Method and apparatus for gryphing a data storage medium
ES2625850T3 (es) * 2006-04-19 2017-07-20 Transmedics, Inc. Procedimientos para el cuidado de órganos ex vivo
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
EP2206504A4 (en) * 2007-10-05 2014-02-12 Univ Chiba Nat Univ Corp STABLE IONIC BICARBONATE MEDICINES SOLUTION
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US8420380B2 (en) 2008-01-31 2013-04-16 Transmedics, Inc. Systems and methods for ex vivo lung care
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DK4032401T3 (da) 2011-04-14 2025-12-15 Transmedics Inc Fremgangsmåde til fremstilling af en organplejeopløsning til maskinperfusion ex-vivo af donorlunger
US8579880B2 (en) * 2012-03-01 2013-11-12 Outcome Solutions, Llc Devices and methods for making and administering an intravenous liquid with supersaturated dissolved gas
CN106659151B (zh) 2014-06-02 2021-06-08 特兰斯迈迪茨公司 离体器官护理系统
CA2970117A1 (en) 2014-12-12 2016-06-16 Darren FREED Apparatus and method for organ perfusion
CN107949419B (zh) 2015-09-09 2021-03-05 特兰斯迈迪茨公司 离体器官护理系统用的主动脉插管
CN114946834B (zh) 2016-05-30 2024-10-25 体沃索股份有限公司 利用变化的外部压力用于离体肺通气的装置和方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3677024A (en) 1970-01-20 1972-07-18 Paul E Segall Preservation and storage of biologic materials
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US4001401A (en) 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
CA1264442A (en) 1984-06-22 1990-01-16 Richard L. Veech Electrolyte solutions and in vivo use thereof
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4908350A (en) 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
US5274001A (en) * 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
CA2066374C (en) 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
EP0663821A4 (en) * 1991-08-08 1997-09-17 Leigh D Segel BLOOD SUBSTITUTE WITH FLUOROCARBON.
US5334142A (en) * 1991-09-09 1994-08-02 New York University Selective aortic perfusion system
US5374428A (en) * 1993-03-23 1994-12-20 Kansas State University Research Foundation Supplementation of protein diets with di- and tripeptides
US5407428A (en) * 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes
PT701455E (pt) * 1993-06-04 2001-09-27 Biotime Inc Solucao semelhante a plasma
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US5730720A (en) 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications

Also Published As

Publication number Publication date
EA003171B1 (ru) 2003-02-27
MXPA01007875A (es) 2002-08-20
US6589223B1 (en) 2003-07-08
EP1150728A4 (en) 2004-09-29
JP2009242404A (ja) 2009-10-22
US6991624B2 (en) 2006-01-31
IL144710A0 (en) 2002-06-30
JP5180912B2 (ja) 2013-04-10
BR0008006A (pt) 2001-12-04
CA2362051A1 (en) 2000-08-10
AR022482A1 (es) 2002-09-04
WO2000045873A1 (en) 2000-08-10
US7503913B2 (en) 2009-03-17
AU765144B2 (en) 2003-09-11
EP1150728A1 (en) 2001-11-07
EA200100855A1 (ru) 2002-02-28
ZA200107243B (en) 2002-09-02
AU3349700A (en) 2000-08-25
CN1346286A (zh) 2002-04-24
JP2002536078A (ja) 2002-10-29
CN1200742C (zh) 2005-05-11
TW542728B (en) 2003-07-21
US20060088606A1 (en) 2006-04-27
US20040018966A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
JP5180912B2 (ja) 灌流の応用における使用のための方法および組成物
US7943292B2 (en) Physiologically acceptable aqueous solutions and methods for their use
US5723281A (en) Plasma-like substance
EP0581883B1 (en) Blood substitutes and organ preservative solutions
US6506549B1 (en) Plasma expanders and blood substitutes
US5407428A (en) Solutions for use as plasma expanders and substitutes
US6627393B2 (en) Solutions for use as plasma expanders and substitutes
US6218099B1 (en) Methods and compositions for use in perfusion applications
WO1996019918A1 (en) Plasma expanders and blood substitutes
US6300322B1 (en) Plasma-like solution
WO1989010746A2 (en) Blood substitute
US20010048951A1 (en) Methods of administering a synthetic plasma like solution, and systems and kits for use in practicing the same
WO1999022746A1 (en) Physiologically acceptable aqueous solutions and methods for their use
Miller In vitro hypothermic preservation of dog kidneys by surface cooling methods or continuous perfusion with emphasis on the effects of warm ischemia on intrarenal hemodynamics

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200124